Endocrine disorders in mitochondrial disease

被引:79
作者
Schaefer, Andrew M. [1 ]
Walker, Mark [2 ]
Turnbull, Douglass M. [1 ]
Taylor, Robert W. [1 ]
机构
[1] Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Inst Ageing & Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
[2] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
基金
英国惠康基金;
关键词
Mitochondrial disease; Endocrine; mtDNA; Diabetes; m.3243A > G; KEARNS-SAYRE-SYNDROME; HEREDITARY OPTIC NEUROPATHY; GROWTH-HORMONE DEFICIENCY; DNA A3243G MUTATION; TO-G MUTATION; TYPE-2; DIABETES-MELLITUS; LACTIC-ACIDOSIS; TRNA(LEU(UUR)) GENE; MTDNA MUTATION; NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY;
D O I
10.1016/j.mce.2013.06.004
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Endocrine dysfunction in mitochondrial disease is commonplace, but predominantly restricted to disease of the endocrine pancreas resulting in diabetes mellitus. Other endocrine manifestations occur, but are relatively rare by comparison. In mitochondrial disease, neuromuscular symptoms often dominate the clinical phenotype, but it is of paramount importance to appreciate the multi-system nature of the disease, of which endocrine dysfunction may be a part. The numerous phenotypes attributable to pathogenic mutations in both the mitochondrial (mtDNA) and nuclear DNA creates a complex and heterogeneous catalogue of disease which can be difficult to navigate for novices and experts alike. In this article we provide an overview of the endocrine disorders associated with mitochondrial disease, the way in which the underlying mitochondrial disorder influences the clinical presentation, and how these factors influence subsequent management. (C) 2013 The Authors. Published by Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:2 / 11
页数:10
相关论文
共 145 条
[1]   Screening for the mitochondrial DNA A3243G mutation in children with insulin-dependent diabetes mellitus [J].
Abad, MM ;
Cotter, PD ;
Fodor, FH ;
Larson, S ;
GinsbergFellner, F ;
Desnick, RJ ;
Abdenur, JE .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1997, 46 (04) :445-449
[2]   Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64) [J].
Adler, AI ;
Stevens, RJ ;
Manley, SE ;
Bilous, RW ;
Cull, CA ;
Holman, RR .
KIDNEY INTERNATIONAL, 2003, 63 (01) :225-232
[3]   SEQUENCE AND ORGANIZATION OF THE HUMAN MITOCHONDRIAL GENOME [J].
ANDERSON, S ;
BANKIER, AT ;
BARRELL, BG ;
DEBRUIJN, MHL ;
COULSON, AR ;
DROUIN, J ;
EPERON, IC ;
NIERLICH, DP ;
ROE, BA ;
SANGER, F ;
SCHREIER, PH ;
SMITH, AJH ;
STADEN, R ;
YOUNG, IG .
NATURE, 1981, 290 (5806) :457-465
[4]  
[Anonymous], CLIN NEUROL
[5]  
[Anonymous], BRAIN DEV
[6]  
[Anonymous], CAN J ANAESTH
[7]   Expanding the phenotype of the 8344 transfer RNAlysine mitochondrial DNA mutation [J].
Austin, SA ;
Vriesendorp, FJ ;
Thandroyen, FT ;
Hecht, JT ;
Jones, OT ;
Johns, DR .
NEUROLOGY, 1998, 51 (05) :1447-1450
[8]   Endocrine disorders in two sisters affected by MELAS syndrome [J].
Balestri, P ;
Grosso, S .
JOURNAL OF CHILD NEUROLOGY, 2000, 15 (11) :755-758
[9]   MITOCHONDRIAL DIABETES REVISITED [J].
BALLINGER, SW ;
SHOFFNER, JM ;
GEBHART, S ;
KOONTZ, DA ;
WALLACE, DC .
NATURE GENETICS, 1994, 7 (04) :458-459
[10]  
Barrientos A, 1997, HUM MUTAT, V10, P212